US Representative

August Pfluger 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 7)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3946

Introduced
6/9/23  
Refer
6/9/23  
FASD Respect Act Advancing FASD Research, Services and Prevention Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3949

Introduced
6/9/23  
Refer
6/9/23  
END CELLS in CELLS Act Eliminate Non-approved Devices and Contraband Electronics Limiting Links to Society in Confined Environments for Longer Lasting Safety Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4006

Introduced
6/12/23  
Refer
6/12/23  
Amateur Radio Emergency Preparedness Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB407

Introduced
1/20/23  
Refer
1/20/23  
Protect the UNBORN (Undo the Negligent Biden Orders Right Now) Act or the Protect the UNBORN Act This bill prohibits federal implementation of and funding for specified executive orders that address access to reproductive health care services, including services related to pregnancy or the termination of a pregnancy.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB412

Introduced
1/20/23  
Designates the facility of the United States Postal Service located at 620 East Pecan Boulevard in McAllen, Texas, as the "Agent Raul H. Gonzalez Jr. Memorial Post Office."
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4136

Introduced
6/14/23  
Refer
6/14/23  
Refer
7/25/23  
U.S. Congressman Sam Johnson Memorial VA Clinic Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB431

Introduced
1/20/23  
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4315

Introduced
6/23/23  
Refer
6/23/23  
Medicare Orthotics and Prosthetics Patient-Centered Care Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4343

Introduced
6/23/23  
Refer
6/23/23  
Organ Donation Clarification Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB435

Introduced
1/20/23  
Protecting Life on College Campus Act of 2023 This bill prohibits the award of federal funds to an institution of higher education (IHE) that hosts or is affiliated with a school-based service site that provides abortion drugs or abortions to its students or to employees of the IHE or the site. An IHE that hosts or is affiliated with a site must, in order to remain eligible for federal funds, annually certify that the site does not provide abortion drugs or abortions to students or employees.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4362

Introduced
6/23/23  
Refer
6/23/23  
Refer
6/23/23  
Saving Organs One Flight at a Time Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4468

Introduced
7/6/23  
Refer
7/6/23  
Refer
7/7/23  
Report Pass
7/27/23  
Choice in Automobile Retail Sales Act of 2023

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4300

Introduced
6/22/23  
Refer
6/22/23  
Refer
6/23/23  
Real Emergencies Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4512

Introduced
7/10/23  
Digital Economy Cybersecurity Advisory Act of 2023